These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38624015)
1. A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus. Pscheidt VM; de Souza PO; Fazolo T; Modena JLP; Simeoni C; Teixeira D; Silva NB; Dos Santos KB; Júnior LR; Bonorino C Cytometry A; 2024 Jun; 105(6):446-457. PubMed ID: 38624015 [TBL] [Abstract][Full Text] [Related]
2. Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays. Valcourt EJ; Manguiat K; Robinson A; Lin YC; Abe KT; Mubareka S; Shigayeva A; Zhong Z; Girardin RC; DuPuis A; Payne A; McDonough K; Wang Z; Gasser R; Laumaea A; Benlarbi M; Richard J; Prévost J; Anand SP; Dimitrova K; Phillipson C; McGeer A; Gingras AC; Liang C; Petric M; Sekirov I; Morshed M; Finzi A; Drebot M; Wood H Microbiol Spectr; 2021 Dec; 9(3):e0088621. PubMed ID: 34787495 [TBL] [Abstract][Full Text] [Related]
3. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization. Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein. Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects. Gillot C; Favresse J; Maloteau V; Dogné JM; Douxfils J Viruses; 2021 Nov; 13(11):. PubMed ID: 34835135 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing. Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830 [TBL] [Abstract][Full Text] [Related]
7. Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein. Horndler L; Delgado P; Abia D; Balabanov I; Martínez-Fleta P; Cornish G; Llamas MA; Serrano-Villar S; Sánchez-Madrid F; Fresno M; van Santen HM; Alarcón B EMBO Mol Med; 2021 Mar; 13(3):e13549. PubMed ID: 33471406 [TBL] [Abstract][Full Text] [Related]
8. A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Solastie A; Virta C; Haveri A; Ekström N; Kantele A; Miettinen S; Lempainen J; Jalkanen P; Kakkola L; Dub T; Julkunen I; Melin M Microbiol Spectr; 2021 Dec; 9(3):e0113121. PubMed ID: 34787485 [TBL] [Abstract][Full Text] [Related]
9. Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19. Tian L; Elsheikh EB; Patrone PN; Kearsley AJ; Gaigalas AK; Inwood S; Lin-Gibson S; Esposito D; Wang L Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800363 [TBL] [Abstract][Full Text] [Related]
10. Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays. Valdivia A; Torres I; Latorre V; Francés-Gómez C; Albert E; Gozalbo-Rovira R; Alcaraz MJ; Buesa J; Rodríguez-Díaz J; Geller R; Navarro D Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):485-494. PubMed ID: 33404891 [TBL] [Abstract][Full Text] [Related]
11. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay. Grenache DG; Ye C; Bradfute SB J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417 [TBL] [Abstract][Full Text] [Related]
12. A flow cytometry-based assay for serological detection of anti-spike antibodies in COVID-19 patients. Goh YS; Ng LFP; Renia L STAR Protoc; 2021 Sep; 2(3):100671. PubMed ID: 34179835 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring. Cristiano A; Pieri M; Sarubbi S; Pelagalli M; Calugi G; Tomassetti F; Bernardini S; Nuccetelli M Clin Immunol; 2022 Jan; 234():108918. PubMed ID: 34971839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]